公开(公告)号：US20240108656A1

公开(公告)日：2024-04-04

申请号：US18539876

申请日：2023-12-14

Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITED

Inventor： Lan Cao ,  Hui-Hsin Chang ,  Jianxin Hu ,  Yu Qian ,  Xi Shi

IPC: A61K35/17 ,  A61K39/00 ,  A61P35/02 ,  C07K14/54 ,  C07K16/28 ,  C12N5/00 ,  C12N5/0783

CPC classification number: A61K35/17 ,  A61K39/4613 ,  A61K39/4631 ,  A61K39/464411 ,  A61K39/46444 ,  A61P35/02 ,  C07K14/5443 ,  C07K16/2803 ,  C12N5/0018 ,  C12N5/0646 ,  A61K2239/13 ,  A61K2239/28 ,  A61K2239/48

Abstract: The present disclosure provides, among other things, a method for efficiently producing a cell population enriched in Natural Killer cells (NK cells) from induced pluripotent cells.